Project Grant K23HD114879
Award Date
6/20/24
Completion Date
5/31/29
Dollars Obligated
$167K
Federal Agency
National Institute of Child Health and Human Development
Federal Grant Program
93.865
Assistance Type
Project Grant
Place of Performance
미국 뉴욕
Similar Awards
The federal Project Grant award K23HL175236 for $392,882, provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research Program (CFDA 93.837), will support research to address racial disparities in chronic lung disease (CLD) for preterm infants. The project aims to: 1) characterize medical and social risk factors associated with respiratory morbidity in preterm infants with CLD, 2) describe the lived experiences of parents of Black preterm infants...
The federal Project Grant award R01HL171069, provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), aims to establish patient-reported outcome measures that can refine neonatal risk stratification and identify barriers to post-discharge specialty care for preterm infants with bronchopulmonary dysplasia (BPD). The $586,021 grant will support a 5-year project to recruit at least 750 infants across 15 sites in the...
This federal Project Grant award of $163,080 from the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) to the Ann & Robert H. Lurie Children's Hospital of Chicago aims to derive, validate, and compare longitudinal prediction models of new or worsening cardiovascular and respiratory dysfunction in critically ill children requiring mechanical ventilation. The project will leverage high-frequency physiological...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research federal grant program (CFDA 93.837) will support Dr. Tyris' research to advance the integration of social and medical care for children with asthma. The $154,861 grant will enable three key aims: 1) developing a machine learning model to predict hospitalization risk among children with asthma using social adversity, clinical, and demographic data; 2) characterizing...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), is providing $781,129 to The Regents of the University of California, San Francisco (UCSF) to conduct a prospective, multicenter cohort study of 400 critically ill children with acute respiratory failure. The key objectives are to: 1) independently validate the performance of UCSF's existing integrated host/microbe...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), will fund a research project to develop and validate a tool to calculate the contribution of each phenotype of bronchopulmonary dysplasia (BPD) to elevated breathing effort in premature neonates. The $773,916 award, effective August 15, 2024 through June 30, 2029, will support the creation of a novel neonate-specific magnetic resonance imaging...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research federal grant program (CFDA 93.837), provides $503,436 to Ann & Robert H. Lurie Children's Hospital of Chicago to develop and validate a clinical prediction model for diagnosing community-acquired pneumonia (CAP) in children. The key objectives are to: 1) derive and internally validate a CAP prediction model using electronic health record data; 2) determine how to...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research federal grant program (CFDA 93.837), will support research to identify the role of myeloid-derived suppressor cells (MDSC) in the immune response of children with severe viral lower respiratory tract infections (LRTI). The $180,199 award, effective September 1, 2024 through August 31, 2029, will enable the Research Institute at Nationwide Children's Hospital to...
This Project Grant award for $753,018 was issued by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research (CFDA 93.837) federal grant program. The primary objective is to conduct a longitudinal study examining early-life predictors of airway-to-lung mismatch, or "dysanapsis," a key risk factor for chronic obstructive pulmonary disease (COPD). The study will leverage 8 diverse pediatric birth cohorts to investigate how factors like obesity,...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $198,720 to The Johns Hopkins University to conduct research focused on understanding the relationship between mechanical ventilation, thromboinflammation, and the risk of hospital-acquired venous thromboembolism (HA-VTE) in critically ill children. The key objectives of this 5-year project are to: 1) determine the impact of...